Pharmaceutical Product Development Retirement Savings Plan
Performance
Help| Portfolio Return | 0.00% | 0.00% | 0.00% |
| Comparable Target-Date Fund [why this comparison?] |
0.00% Target-Date 2020 |
0.00% Target-Date 2030 |
0.00% Target-Date 2050 |
| Value-added by Kivalia ($100k starting amount) |
0.0 (0.0%) | 0.0 (0.0%) | 0.0 (0.0%) |
Current Recommendations
(as of 9/30/2020)Help| NAME | TICKER | CONSERVATIVE | MODERATE | AGGRESSIVE |
|---|---|---|---|---|
| Vanguard Institutional Index Fund Institutional Shares | VINIX | 21% | 40% | 68% |
| Fidelity Freedom 2010 Fund | FFFCX | 38% | 24% | - |
| Fidelity Freedom 2040 Fund | FFFFX | 24% | 24% | 9% |
| MFS Total Return Fund Class R4 | MSFJX | 8% | - | - |
| JPMorgan Core Bond Fund Class R5 | JCBRX | 9% | - | - |
| Victory Sycamore Small Company Opportunity Fund Class I | VSOIX | - | 7% | 9% |
| MFS Growth Fund Class R6 | MFEKX | - | 5% | 7% |
| JPMorgan Small Cap Equity Fund Select Class | VSEIX | - | - | 7% |
| Total Portfolio | 100% | 100% | 100% |